Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 13 |
NetGPI | no | yes: 0, no: 13 |
Related structures:
AlphaFold database: Q4QDL3
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0008270 | zinc ion binding | 6 | 1 |
GO:0043167 | ion binding | 2 | 1 |
GO:0043169 | cation binding | 3 | 1 |
GO:0046872 | metal ion binding | 4 | 1 |
GO:0046914 | transition metal ion binding | 5 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 296 | 300 | PF00656 | 0.596 |
CLV_NRD_NRD_1 | 104 | 106 | PF00675 | 0.651 |
CLV_NRD_NRD_1 | 157 | 159 | PF00675 | 0.507 |
CLV_NRD_NRD_1 | 179 | 181 | PF00675 | 0.452 |
CLV_NRD_NRD_1 | 190 | 192 | PF00675 | 0.495 |
CLV_NRD_NRD_1 | 214 | 216 | PF00675 | 0.449 |
CLV_NRD_NRD_1 | 266 | 268 | PF00675 | 0.482 |
CLV_NRD_NRD_1 | 302 | 304 | PF00675 | 0.605 |
CLV_NRD_NRD_1 | 375 | 377 | PF00675 | 0.512 |
CLV_NRD_NRD_1 | 388 | 390 | PF00675 | 0.464 |
CLV_NRD_NRD_1 | 398 | 400 | PF00675 | 0.418 |
CLV_NRD_NRD_1 | 69 | 71 | PF00675 | 0.526 |
CLV_PCSK_FUR_1 | 214 | 218 | PF00082 | 0.439 |
CLV_PCSK_KEX2_1 | 157 | 159 | PF00082 | 0.540 |
CLV_PCSK_KEX2_1 | 178 | 180 | PF00082 | 0.448 |
CLV_PCSK_KEX2_1 | 189 | 191 | PF00082 | 0.447 |
CLV_PCSK_KEX2_1 | 214 | 216 | PF00082 | 0.473 |
CLV_PCSK_KEX2_1 | 258 | 260 | PF00082 | 0.516 |
CLV_PCSK_KEX2_1 | 265 | 267 | PF00082 | 0.510 |
CLV_PCSK_KEX2_1 | 302 | 304 | PF00082 | 0.635 |
CLV_PCSK_KEX2_1 | 336 | 338 | PF00082 | 0.488 |
CLV_PCSK_KEX2_1 | 377 | 379 | PF00082 | 0.557 |
CLV_PCSK_KEX2_1 | 387 | 389 | PF00082 | 0.495 |
CLV_PCSK_KEX2_1 | 398 | 400 | PF00082 | 0.425 |
CLV_PCSK_KEX2_1 | 59 | 61 | PF00082 | 0.289 |
CLV_PCSK_KEX2_1 | 69 | 71 | PF00082 | 0.465 |
CLV_PCSK_PC1ET2_1 | 178 | 180 | PF00082 | 0.460 |
CLV_PCSK_PC1ET2_1 | 216 | 218 | PF00082 | 0.637 |
CLV_PCSK_PC1ET2_1 | 258 | 260 | PF00082 | 0.583 |
CLV_PCSK_PC1ET2_1 | 336 | 338 | PF00082 | 0.530 |
CLV_PCSK_PC1ET2_1 | 377 | 379 | PF00082 | 0.505 |
CLV_PCSK_PC1ET2_1 | 59 | 61 | PF00082 | 0.294 |
CLV_PCSK_PC7_1 | 175 | 181 | PF00082 | 0.569 |
CLV_PCSK_PC7_1 | 185 | 191 | PF00082 | 0.566 |
CLV_PCSK_PC7_1 | 210 | 216 | PF00082 | 0.577 |
CLV_PCSK_PC7_1 | 65 | 71 | PF00082 | 0.590 |
CLV_PCSK_SKI1_1 | 108 | 112 | PF00082 | 0.640 |
CLV_PCSK_SKI1_1 | 200 | 204 | PF00082 | 0.569 |
CLV_PCSK_SKI1_1 | 210 | 214 | PF00082 | 0.575 |
CLV_PCSK_SKI1_1 | 416 | 420 | PF00082 | 0.464 |
CLV_PCSK_SKI1_1 | 65 | 69 | PF00082 | 0.592 |
CLV_Separin_Metazoa | 211 | 215 | PF03568 | 0.472 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.609 |
DOC_CYCLIN_RxL_1 | 22 | 35 | PF00134 | 0.270 |
DOC_USP7_MATH_1 | 101 | 105 | PF00917 | 0.543 |
DOC_USP7_MATH_1 | 84 | 88 | PF00917 | 0.635 |
DOC_USP7_MATH_1 | 91 | 95 | PF00917 | 0.587 |
DOC_USP7_UBL2_3 | 225 | 229 | PF12436 | 0.445 |
DOC_WW_Pin1_4 | 123 | 128 | PF00397 | 0.580 |
DOC_WW_Pin1_4 | 85 | 90 | PF00397 | 0.605 |
LIG_14-3-3_CanoR_1 | 108 | 116 | PF00244 | 0.646 |
LIG_14-3-3_CanoR_1 | 137 | 145 | PF00244 | 0.622 |
LIG_14-3-3_CanoR_1 | 365 | 372 | PF00244 | 0.635 |
LIG_Actin_WH2_2 | 401 | 418 | PF00022 | 0.454 |
LIG_APCC_ABBA_1 | 30 | 35 | PF00400 | 0.270 |
LIG_FHA_1 | 367 | 373 | PF00498 | 0.565 |
LIG_FHA_1 | 399 | 405 | PF00498 | 0.460 |
LIG_FHA_1 | 422 | 428 | PF00498 | 0.633 |
LIG_FHA_2 | 142 | 148 | PF00498 | 0.618 |
LIG_FHA_2 | 366 | 372 | PF00498 | 0.620 |
LIG_FHA_2 | 51 | 57 | PF00498 | 0.386 |
LIG_FHA_2 | 66 | 72 | PF00498 | 0.520 |
LIG_LIR_Gen_1 | 234 | 242 | PF02991 | 0.474 |
LIG_LIR_Gen_1 | 5 | 12 | PF02991 | 0.312 |
LIG_LIR_Nem_3 | 118 | 123 | PF02991 | 0.525 |
LIG_LIR_Nem_3 | 133 | 139 | PF02991 | 0.691 |
LIG_LIR_Nem_3 | 234 | 239 | PF02991 | 0.529 |
LIG_LIR_Nem_3 | 41 | 47 | PF02991 | 0.291 |
LIG_LIR_Nem_3 | 5 | 10 | PF02991 | 0.312 |
LIG_PCNA_PIPBox_1 | 244 | 253 | PF02747 | 0.467 |
LIG_Pex14_2 | 145 | 149 | PF04695 | 0.477 |
LIG_RPA_C_Fungi | 261 | 273 | PF08784 | 0.484 |
LIG_SH2_CRK | 51 | 55 | PF00017 | 0.319 |
LIG_SH2_CRK | 7 | 11 | PF00017 | 0.332 |
LIG_SH2_NCK_1 | 236 | 240 | PF00017 | 0.489 |
LIG_SH2_SRC | 236 | 239 | PF00017 | 0.571 |
LIG_SH2_STAP1 | 169 | 173 | PF00017 | 0.472 |
LIG_SH2_STAP1 | 63 | 67 | PF00017 | 0.427 |
LIG_SH2_STAT5 | 7 | 10 | PF00017 | 0.376 |
LIG_SH3_3 | 83 | 89 | PF00018 | 0.617 |
LIG_TRAF2_1 | 330 | 333 | PF00917 | 0.626 |
LIG_TRAF2_1 | 338 | 341 | PF00917 | 0.601 |
LIG_TRAF2_1 | 361 | 364 | PF00917 | 0.550 |
MOD_CK1_1 | 126 | 132 | PF00069 | 0.693 |
MOD_CK1_1 | 141 | 147 | PF00069 | 0.577 |
MOD_CK2_1 | 141 | 147 | PF00069 | 0.538 |
MOD_CK2_1 | 365 | 371 | PF00069 | 0.664 |
MOD_GlcNHglycan | 128 | 131 | PF01048 | 0.627 |
MOD_GlcNHglycan | 391 | 397 | PF01048 | 0.611 |
MOD_GlcNHglycan | 60 | 63 | PF01048 | 0.401 |
MOD_N-GLC_1 | 365 | 370 | PF02516 | 0.477 |
MOD_NEK2_1 | 10 | 15 | PF00069 | 0.400 |
MOD_PIKK_1 | 253 | 259 | PF00454 | 0.536 |
MOD_PKA_1 | 398 | 404 | PF00069 | 0.463 |
MOD_PKA_2 | 282 | 288 | PF00069 | 0.721 |
MOD_PKA_2 | 366 | 372 | PF00069 | 0.517 |
MOD_PKA_2 | 398 | 404 | PF00069 | 0.456 |
MOD_Plk_1 | 392 | 398 | PF00069 | 0.606 |
MOD_Plk_4 | 5 | 11 | PF00069 | 0.395 |
MOD_ProDKin_1 | 123 | 129 | PF00069 | 0.581 |
MOD_ProDKin_1 | 85 | 91 | PF00069 | 0.608 |
MOD_SUMO_for_1 | 165 | 168 | PF00179 | 0.582 |
MOD_SUMO_for_1 | 324 | 327 | PF00179 | 0.622 |
MOD_SUMO_for_1 | 410 | 413 | PF00179 | 0.549 |
MOD_SUMO_rev_2 | 218 | 227 | PF00179 | 0.550 |
MOD_SUMO_rev_2 | 299 | 308 | PF00179 | 0.560 |
MOD_SUMO_rev_2 | 327 | 335 | PF00179 | 0.466 |
MOD_SUMO_rev_2 | 402 | 410 | PF00179 | 0.503 |
MOD_SUMO_rev_2 | 428 | 432 | PF00179 | 0.581 |
TRG_DiLeu_BaEn_4 | 196 | 202 | PF01217 | 0.351 |
TRG_DiLeu_BaEn_4 | 263 | 269 | PF01217 | 0.537 |
TRG_DiLeu_BaEn_4 | 339 | 345 | PF01217 | 0.561 |
TRG_ENDOCYTIC_2 | 236 | 239 | PF00928 | 0.454 |
TRG_ENDOCYTIC_2 | 51 | 54 | PF00928 | 0.307 |
TRG_ENDOCYTIC_2 | 6 | 9 | PF00928 | 0.318 |
TRG_ER_diArg_1 | 156 | 158 | PF00400 | 0.662 |
TRG_ER_diArg_1 | 179 | 181 | PF00400 | 0.524 |
TRG_ER_diArg_1 | 189 | 191 | PF00400 | 0.528 |
TRG_ER_diArg_1 | 213 | 215 | PF00400 | 0.468 |
TRG_ER_diArg_1 | 265 | 267 | PF00400 | 0.452 |
TRG_ER_diArg_1 | 301 | 303 | PF00400 | 0.659 |
TRG_ER_diArg_1 | 376 | 379 | PF00400 | 0.658 |
TRG_ER_diArg_1 | 387 | 389 | PF00400 | 0.474 |
TRG_ER_diArg_1 | 397 | 399 | PF00400 | 0.428 |
TRG_NLS_MonoCore_2 | 104 | 109 | PF00514 | 0.614 |
TRG_Pf-PMV_PEXEL_1 | 137 | 142 | PF00026 | 0.457 |
TRG_Pf-PMV_PEXEL_1 | 249 | 253 | PF00026 | 0.518 |
TRG_Pf-PMV_PEXEL_1 | 259 | 263 | PF00026 | 0.435 |
TRG_Pf-PMV_PEXEL_1 | 266 | 270 | PF00026 | 0.414 |
TRG_Pf-PMV_PEXEL_1 | 342 | 347 | PF00026 | 0.577 |
TRG_Pf-PMV_PEXEL_1 | 378 | 382 | PF00026 | 0.479 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I0G8 | Leptomonas seymouri | 71% | 100% |
A0A0S4IRH8 | Bodo saltans | 44% | 97% |
A0A0S4J1C8 | Bodo saltans | 29% | 93% |
A0A0S4JH45 | Bodo saltans | 25% | 100% |
A0A1X0P7B2 | Trypanosomatidae | 49% | 97% |
A0A3Q8IA51 | Leishmania donovani | 97% | 100% |
A0A3R7MIW9 | Trypanosoma rangeli | 51% | 97% |
A4H9W5 | Leishmania braziliensis | 90% | 100% |
D0A0C8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 48% | 98% |
E9AGR0 | Leishmania infantum | 98% | 100% |
E9ARV9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |
V5BWX2 | Trypanosoma cruzi | 50% | 97% |